APA (7th ed.) Citation

Mao, X., Zhang, X., Lai, R., Cheung, K., Yuen, M., Cheung, R., . . . Nguyen, M. H. (2025). Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: A target trial emulation study. Korean Association for the Study of the Liver.

Chicago Style (17th ed.) Citation

Mao, Xianhua, Xinrong Zhang, Rongtao Lai, Ka-Shing Cheung, Man-Fung Yuen, Ramsey Cheung, Wai-Kay Seto, and Mindie H. Nguyen. Glucagon-like Peptide 1 Receptor Agonist and Reduced Liver and Non-liver Complications in Adults with Type 2 Diabetes and Metabolic Dysfunction-associated Steatotic Liver Disease: A Target Trial Emulation Study. Korean Association for the Study of the Liver, 2025.

MLA (9th ed.) Citation

Mao, Xianhua, et al. Glucagon-like Peptide 1 Receptor Agonist and Reduced Liver and Non-liver Complications in Adults with Type 2 Diabetes and Metabolic Dysfunction-associated Steatotic Liver Disease: A Target Trial Emulation Study. Korean Association for the Study of the Liver, 2025.